Taysha Gene Therapies, Inc. TSHA Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s non-cash lease expense?
- Taysha Gene Therapies, Inc. (TSHA) reported non-cash lease expense of $285K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s non-cash lease expense changed year-over-year?
- Taysha Gene Therapies, Inc.'s non-cash lease expense decreased by 15.9% year-over-year, from $339K to $285K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s non-cash lease expense?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s non-cash lease expense has grown at a 1.1% compound annual growth rate (CAGR), from $1.32M to $1.36M.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.